| Disease | lipodystrophy |
| Comorbidity | C0020456|hyperglycaemia |
| Sentences | 1 |
| PubMedID- 23740412 | The compound is expected to improve insulin sensitivity, hypertriglyceridaemia and hyperglycaemia in patients with lipodystrophy who are unresponsive to conventional treatment. |
Page: 1